Free Trial

AerCap (AER) Competitors

$90.99
+0.86 (+0.95%)
(As of 06/12/2024 ET)

AER vs. RPRX, SOFI, CCCS, TRTN, URI, AL, MGRC, UPBD, PRG, and CTOS

Should you be buying AerCap stock or one of its competitors? The main competitors of AerCap include Royalty Pharma (RPRX), SoFi Technologies (SOFI), CCC Intelligent Solutions (CCCS), Triton International (TRTN), United Rentals (URI), Air Lease (AL), McGrath RentCorp (MGRC), Upbound Group (UPBD), PROG (PRG), and Custom Truck One Source (CTOS).

AerCap vs.

Royalty Pharma (NASDAQ:RPRX) and AerCap (NYSE:AER) are both large-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, community ranking, valuation, dividends and profitability.

AerCap has a net margin of 42.78% compared to AerCap's net margin of 35.70%. AerCap's return on equity of 22.94% beat Royalty Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Royalty Pharma35.70% 22.94% 13.78%
AerCap 42.78%15.29%3.57%

Royalty Pharma has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500. Comparatively, AerCap has a beta of 1.85, meaning that its share price is 85% more volatile than the S&P 500.

54.3% of Royalty Pharma shares are owned by institutional investors. Comparatively, 96.4% of AerCap shares are owned by institutional investors. 18.9% of Royalty Pharma shares are owned by insiders. Comparatively, 0.5% of AerCap shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

AerCap received 232 more outperform votes than Royalty Pharma when rated by MarketBeat users. Likewise, 74.25% of users gave AerCap an outperform vote while only 67.81% of users gave Royalty Pharma an outperform vote.

CompanyUnderperformOutperform
Royalty PharmaOutperform Votes
316
67.81%
Underperform Votes
150
32.19%
AerCapOutperform Votes
548
74.25%
Underperform Votes
190
25.75%

AerCap has higher revenue and earnings than Royalty Pharma. AerCap is trading at a lower price-to-earnings ratio than Royalty Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Royalty Pharma$2.24B7.25$1.13B$1.3420.28
AerCap$7.58B2.38$3.14B$15.375.92

In the previous week, AerCap had 2 more articles in the media than Royalty Pharma. MarketBeat recorded 9 mentions for AerCap and 7 mentions for Royalty Pharma. Royalty Pharma's average media sentiment score of 1.37 beat AerCap's score of 1.20 indicating that AerCap is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Royalty Pharma
6 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AerCap
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Royalty Pharma currently has a consensus target price of $43.00, indicating a potential upside of 57.91%. AerCap has a consensus target price of $97.56, indicating a potential upside of 7.42%. Given AerCap's higher probable upside, equities research analysts plainly believe Royalty Pharma is more favorable than AerCap.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Royalty Pharma
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
AerCap
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89

Royalty Pharma pays an annual dividend of $0.84 per share and has a dividend yield of 3.1%. AerCap pays an annual dividend of $1.00 per share and has a dividend yield of 1.1%. Royalty Pharma pays out 62.7% of its earnings in the form of a dividend. AerCap pays out 6.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Royalty Pharma has raised its dividend for 4 consecutive years. Royalty Pharma is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

AerCap beats Royalty Pharma on 13 of the 21 factors compared between the two stocks.

Get AerCap News Delivered to You Automatically

Sign up to receive the latest news and ratings for AER and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AER and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AER vs. The Competition

MetricAerCapEquipment rental & leasing IndustryFinance SectorNYSE Exchange
Market Cap$18.01B$6.06B$9.15B$17.66B
Dividend Yield1.09%2.41%10.53%3.58%
P/E Ratio5.9210.8558.0823.96
Price / Sales2.381.453,486.5714.43
Price / Cash3.603.6427.5619.22
Price / Book1.112.182.314.97
Net Income$3.14B$542.12M$1.01B$975.80M
7 Day Performance-0.80%0.04%-0.30%0.14%
1 Month Performance-0.19%0.70%-0.40%-0.89%
1 Year Performance50.56%11.08%9.44%9.83%

AerCap Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RPRX
Royalty Pharma
4.9054 of 5 stars
$27.46
+1.4%
$43.00
+56.6%
-16.7%$16.41B$2.36B20.4951Positive News
SOFI
SoFi Technologies
2.8576 of 5 stars
$6.99
-1.3%
$9.08
+29.9%
-14.4%$7.39B$2.12B-22.554,400Gap Up
CCCS
CCC Intelligent Solutions
1.8794 of 5 stars
$11.48
+0.3%
$13.63
+18.7%
+6.0%$7.14B$866.38M-54.672,325Positive News
TRTN
Triton International
0 of 5 stars
$79.55
flat
N/A-4.4%$4.38B$1.68B7.75244Analyst Forecast
Gap Up
High Trading Volume
URI
United Rentals
4.3301 of 5 stars
$643.40
+2.0%
$612.73
-4.8%
+61.3%$42.84B$14.53B17.4326,300Positive News
AL
Air Lease
4.9587 of 5 stars
$45.94
-0.6%
$53.80
+17.1%
+8.7%$5.12B$2.68B9.26163Short Interest ↓
MGRC
McGrath RentCorp
3.9289 of 5 stars
$105.34
-1.2%
$116.00
+10.1%
+5.2%$2.59B$831.84M20.531,204Dividend Announcement
News Coverage
UPBD
Upbound Group
2.9964 of 5 stars
$32.79
-1.0%
$39.14
+19.4%
-5.9%$1.79B$3.99B-71.2812,970Gap Up
PRG
PROG
2.8473 of 5 stars
$35.65
-1.9%
$39.60
+11.1%
+3.9%$1.54B$2.41B14.551,606Positive News
Gap Up
CTOS
Custom Truck One Source
3.0307 of 5 stars
$4.68
-1.9%
$7.80
+66.7%
-33.9%$1.13B$1.87B46.802,580Short Interest ↑

Related Companies and Tools

This page (NYSE:AER) was last updated on 6/12/2024 by MarketBeat.com Staff

From Our Partners